These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 16760325

  • 1. Type-specific antibodies to pneumococcal capsular polysaccharide acquired either naturally or after vaccination with Prevenar in children with underlying chronic or recurrent lung diseases.
    Navarro D, Escribano A, Cebrián L, Gimeno C, García-Maset L, García-de-Lomas J, Spanish Pneumococcal Infection Study Network.
    Clin Vaccine Immunol; 2006 Jun; 13(6):665-70. PubMed ID: 16760325
    [Abstract] [Full Text] [Related]

  • 2. Total and serotype-specific pneumococcal antibody titres in children with normal and abnormal humoral immunity.
    Uddin S, Borrow R, Haeney MR, Moran A, Warrington R, Balmer P, Arkwright PD.
    Vaccine; 2006 Jul 07; 24(27-28):5637-44. PubMed ID: 16730399
    [Abstract] [Full Text] [Related]

  • 3. Long-term antibody levels and booster responses in South African children immunized with nonavalent pneumococcal conjugate vaccine.
    Huebner RE, Mbelle N, Forrest B, Madore DV, Klugman KP.
    Vaccine; 2004 Jul 29; 22(21-22):2696-700. PubMed ID: 15246599
    [Abstract] [Full Text] [Related]

  • 4. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma.
    Landgren O, Björkholm M, Konradsen HB, Söderqvist M, Nilsson B, Gustavsson A, Axdorph U, Kalin M, Grimfors G.
    J Intern Med; 2004 Jun 29; 255(6):664-73. PubMed ID: 15147530
    [Abstract] [Full Text] [Related]

  • 5. The 23-valent pneumococcal polysaccharide vaccine does not provide additional serotype antibody protection in children who have been primed with two doses of heptavalent pneumococcal conjugate vaccine.
    Balmer P, Borrow R, Arkwright PD.
    Vaccine; 2007 Aug 21; 25(34):6321-5. PubMed ID: 17629373
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Herd immunity and pneumococcal conjugate vaccine: a quantitative model.
    Haber M, Barskey A, Baughman W, Barker L, Whitney CG, Shaw KM, Orenstein W, Stephens DS.
    Vaccine; 2007 Jul 20; 25(29):5390-8. PubMed ID: 17583392
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunoglobulins and immunogenicity of pneumococcal vaccination in preschool asthma.
    Rose MA, Schubert R, Kujumdshiev S, Kitz R, Zielen S.
    Int J Clin Pract; 2006 Nov 20; 60(11):1425-31. PubMed ID: 17073839
    [Abstract] [Full Text] [Related]

  • 10. Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies.
    Siber GR, Chang I, Baker S, Fernsten P, O'Brien KL, Santosham M, Klugman KP, Madhi SA, Paradiso P, Kohberger R.
    Vaccine; 2007 May 10; 25(19):3816-26. PubMed ID: 17368878
    [Abstract] [Full Text] [Related]

  • 11. Effect of combined pneumococcal conjugate and polysaccharide vaccination on recurrent otitis media with effusion.
    van Heerbeek N, Straetemans M, Wiertsema SP, Ingels KJ, Rijkers GT, Schilder AG, Sanders EA, Zielhuis GA.
    Pediatrics; 2006 Mar 10; 117(3):603-8. PubMed ID: 16510637
    [Abstract] [Full Text] [Related]

  • 12. IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.
    Soininen A, Nohynek H, Lucero M, Jousimies K, Ugpo J, Williams G, Käyhty H, ARIVAC Consortium.
    Vaccine; 2009 May 05; 27(20):2680-8. PubMed ID: 19428879
    [Abstract] [Full Text] [Related]

  • 13. Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.
    Abzug MJ, Pelton SI, Song LY, Fenton T, Levin MJ, Nachman SA, Borkowsky W, Rosenblatt HM, Marcinak JF, Dieudonne A, Abrams EJ, Pathak I, Pediatric AIDS Clinical Trials Group P1024 Protocol Team.
    Pediatr Infect Dis J; 2006 Oct 05; 25(10):920-9. PubMed ID: 17006288
    [Abstract] [Full Text] [Related]

  • 14. Pneumococcal conjugate vaccination does not induce a persisting mucosal IgA response in children with recurrent acute otitis media.
    Bogaert D, Veenhoven RH, Ramdin R, Luijendijk IH, Rijkers GT, Sanders EA, de Groot R, Hermans PW.
    Vaccine; 2005 Apr 08; 23(20):2607-13. PubMed ID: 15780443
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Randomised revaccination with pneumococcal polysaccharide or conjugate vaccine in asplenic children previously vaccinated with polysaccharide vaccine.
    Smets F, Bourgois A, Vermylen C, Brichard B, Slacmuylders P, Leyman S, Sokal E.
    Vaccine; 2007 Jul 20; 25(29):5278-82. PubMed ID: 17576024
    [Abstract] [Full Text] [Related]

  • 17. Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children.
    Henckaerts I, Durant N, De Grave D, Schuerman L, Poolman J.
    Vaccine; 2007 Mar 22; 25(13):2518-27. PubMed ID: 17034907
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparative immune responses of patients with chronic pulmonary diseases during the 2-year period after pneumococcal vaccination.
    Chen M, Hisatomi Y, Furumoto A, Kawakami K, Masaki H, Nagatake T, Sueyasu Y, Iwanaga T, Aizawa H, Oishi K.
    Clin Vaccine Immunol; 2007 Feb 22; 14(2):139-45. PubMed ID: 17167035
    [Abstract] [Full Text] [Related]

  • 20. Immunogenicity of pneumococcal vaccination of patients with cochlear implants.
    Rose M, Hey C, Kujumdshiev S, Gall V, Schubert R, Zielen S.
    J Infect Dis; 2004 Aug 01; 190(3):551-7. PubMed ID: 15243931
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.